Strategic Assessment for Portfolio Expansion of an Animal Health Pharma Company
A global animal health pharmaceutical client engaged Stellarix to gain end-to-end visibility into the nsMRA landscape relevant to feline chronic kidney disease (CKD). Our actionable intelligence enabled the firm to strengthen its competitive position by expanding its portfolio, streamlining partner shortlisting & prioritizing, and identifying market gaps. Client Background: A global animal health pharmaceutical company […]
Market Assessment and Capacity Planning for Pancreatic Cancer CDMO Entry
A global Contract Development and Manufacturing Organization (CDMO) sought Stellarix’s support to assess the strategic and financial viability of pancreatic cancer-focused manufacturing devices. Our strategic intelligence enabled demand-driven capacity planning and informed market entry through effective risk mitigation and clear market visibility. Client Background: A global Contract Development and Manufacturing Organization (CDMO) intended to evaluate […]
Improving Competitiveness of a Biopharma Leader through Psilocybin Landscape Mapping
A global biopharma leader engaged us to conduct a comprehensive therapeutic landscape assessment to expand its innovation portfolio with next-generation therapies for treatment-resistant neurological disorders. Stellarix helped the client sharpen its competitive position and innovation edge through an improved portfolio strategy and faster, data-driven decision-making. Client Background: A global biopharmaceutical company focused on central nervous […]
Mental Health Innovation: Why Psychedelic Therapies are Attracting Big Pharma?
Psychedelic therapies are witnessing an exponential surge in the mental health space. This resurgence stems from simplified or relaxed regulatory barriers, shifts in public perception, and the lack of new psychopharmacological options in the psychiatry pipeline. Additionally, rigorous scientific research on psychedelic drugs and evidence of efficacy from clinical trials are also adding to their […]
Technology Landscape – Biodegradable Capsule Suspension
A renowned C&M industry client engaged Stellairx to assess the global technology landscape for bio-based encapsulation to determine potential market opportunities and reinforce its market position. The insights provided by our chemical consulting team helped the client devise a strategic roadmap for future collaboration and market entry, thereby enhancing business resilience. Client Background: A global […]
Navigating Global Regulatory Challenges in Pharma: 2025 and Beyond
The pharmaceutical industry is one of the most regulated industries in the world. The regulatory environment is changing rapidly as we approach 2026 due to progress in drug development, changes in digital health technologies, and other implications of geopolitical changes. Companies must deal with intricate compliance obligations, global interoperability, and emerging trends in their regulated […]
Pharma’s Eco Pill- Sustainable Packaging
Given the growing environmental issues, the pharmaceutical industry is facing increasing pressure to implement sustainable practices. One major area of emphasis is packaging. Most conventional medicinal packaging has been deemed incongruous due to environmental concerns, including its high plastic content and use of non-recyclable materials. The management of packaging waste is now one of the […]
Technology Overview – Active Drug Delivery System
A leading healthcare company sought our assistance to embrace innovative solutions in drug delivery. Our strategic intelligence equipped them with actionable insights to accelerate their innovation pipeline, restructure their R&D efforts, make well-informed investment decisions, and establish strategic partnerships. Client Background: The client is an established healthcare leader, committed to advancing drug delivery through innovative […]
Beyond Appetite: Discovering Hidden Opportunities in the GLP-1 Era
In just a few short years, GLP-1 receptor agonists have transformed from specialized diabetes medications to household names. Drugs like Ozempic, Wegovy, Mounjaro, and Zepbound dominate headlines, social media discussions, and increasingly, medicine cabinets across the country. While their weight loss benefits have captured public attention, the true revolution extends far beyond the bathroom scale. […]
Trump’s Pharma Tariffs: Risks, Impact & Strategy
This is not a recent development; it started with the end of Trump’s first term. During the last quarter, executive orders were issued to cut down the costs of medicines. However, the federal court dismissed the motion, citing that this motion didn’t involve public opinion. The Biden administration also attempted it with the IRA when […]